Medical Care
Global Binge Eating Disorder Treatment Market Research Report 2025
- Jul 08, 25
- ID: 348218
- Pages: 88
- Figures: 81
- Views: 1
The global market for Binge Eating Disorder Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Binge Eating Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Binge Eating Disorder Treatment.
The Binge Eating Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Binge Eating Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Binge Eating Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
Segment by Type
Medication
Services
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Binge Eating Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Binge Eating Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Binge Eating Disorder Treatment.
The Binge Eating Disorder Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Binge Eating Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Binge Eating Disorder Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chronos Therapeutics
Shire US Inc. (part of Takeda Pharmaceutical Company)
Eli Lilly and Company
Sunovion Pharmaceuticals Inc
Promises Behavioral Health
Pyramid Healthcare (Tapestry Eating Disorder Services)
Timberline Knolls
Rosewood Centers for Eating Disorders
Walden Behavioral Care
Roche
Opiant Pharmaceuticals
Heptares
Novo Nordisk
Omeros Corp
Segment by Type
Medication
Services
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Binge Eating Disorder Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Binge Eating Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Services
1.3 Market by Application
1.3.1 Global Binge Eating Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Binge Eating Disorder Treatment Market Perspective (2020-2031)
2.2 Global Binge Eating Disorder Treatment Growth Trends by Region
2.2.1 Global Binge Eating Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Binge Eating Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Binge Eating Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Binge Eating Disorder Treatment Market Dynamics
2.3.1 Binge Eating Disorder Treatment Industry Trends
2.3.2 Binge Eating Disorder Treatment Market Drivers
2.3.3 Binge Eating Disorder Treatment Market Challenges
2.3.4 Binge Eating Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Binge Eating Disorder Treatment Players by Revenue
3.1.1 Global Top Binge Eating Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Binge Eating Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Binge Eating Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Binge Eating Disorder Treatment Revenue
3.4 Global Binge Eating Disorder Treatment Market Concentration Ratio
3.4.1 Global Binge Eating Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Binge Eating Disorder Treatment Revenue in 2024
3.5 Global Key Players of Binge Eating Disorder Treatment Head office and Area Served
3.6 Global Key Players of Binge Eating Disorder Treatment, Product and Application
3.7 Global Key Players of Binge Eating Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Binge Eating Disorder Treatment Breakdown Data by Type
4.1 Global Binge Eating Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Binge Eating Disorder Treatment Breakdown Data by Application
5.1 Global Binge Eating Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Binge Eating Disorder Treatment Market Size (2020-2031)
6.2 North America Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Binge Eating Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Binge Eating Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Binge Eating Disorder Treatment Market Size (2020-2031)
7.2 Europe Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Binge Eating Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Binge Eating Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Binge Eating Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Binge Eating Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Binge Eating Disorder Treatment Market Size (2020-2031)
9.2 Latin America Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Binge Eating Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Binge Eating Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Binge Eating Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chronos Therapeutics
11.1.1 Chronos Therapeutics Company Details
11.1.2 Chronos Therapeutics Business Overview
11.1.3 Chronos Therapeutics Binge Eating Disorder Treatment Introduction
11.1.4 Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.1.5 Chronos Therapeutics Recent Development
11.2 Shire US Inc. (part of Takeda Pharmaceutical Company)
11.2.1 Shire US Inc. (part of Takeda Pharmaceutical Company) Company Details
11.2.2 Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
11.2.3 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Introduction
11.2.4 Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.2.5 Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Binge Eating Disorder Treatment Introduction
11.3.4 Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sunovion Pharmaceuticals Inc
11.4.1 Sunovion Pharmaceuticals Inc Company Details
11.4.2 Sunovion Pharmaceuticals Inc Business Overview
11.4.3 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Introduction
11.4.4 Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.4.5 Sunovion Pharmaceuticals Inc Recent Development
11.5 Promises Behavioral Health
11.5.1 Promises Behavioral Health Company Details
11.5.2 Promises Behavioral Health Business Overview
11.5.3 Promises Behavioral Health Binge Eating Disorder Treatment Introduction
11.5.4 Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.5.5 Promises Behavioral Health Recent Development
11.6 Pyramid Healthcare (Tapestry Eating Disorder Services)
11.6.1 Pyramid Healthcare (Tapestry Eating Disorder Services) Company Details
11.6.2 Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
11.6.3 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Introduction
11.6.4 Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.6.5 Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
11.7 Timberline Knolls
11.7.1 Timberline Knolls Company Details
11.7.2 Timberline Knolls Business Overview
11.7.3 Timberline Knolls Binge Eating Disorder Treatment Introduction
11.7.4 Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.7.5 Timberline Knolls Recent Development
11.8 Rosewood Centers for Eating Disorders
11.8.1 Rosewood Centers for Eating Disorders Company Details
11.8.2 Rosewood Centers for Eating Disorders Business Overview
11.8.3 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Introduction
11.8.4 Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.8.5 Rosewood Centers for Eating Disorders Recent Development
11.9 Walden Behavioral Care
11.9.1 Walden Behavioral Care Company Details
11.9.2 Walden Behavioral Care Business Overview
11.9.3 Walden Behavioral Care Binge Eating Disorder Treatment Introduction
11.9.4 Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.9.5 Walden Behavioral Care Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Binge Eating Disorder Treatment Introduction
11.10.4 Roche Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Opiant Pharmaceuticals
11.11.1 Opiant Pharmaceuticals Company Details
11.11.2 Opiant Pharmaceuticals Business Overview
11.11.3 Opiant Pharmaceuticals Binge Eating Disorder Treatment Introduction
11.11.4 Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.11.5 Opiant Pharmaceuticals Recent Development
11.12 Heptares
11.12.1 Heptares Company Details
11.12.2 Heptares Business Overview
11.12.3 Heptares Binge Eating Disorder Treatment Introduction
11.12.4 Heptares Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.12.5 Heptares Recent Development
11.13 Novo Nordisk
11.13.1 Novo Nordisk Company Details
11.13.2 Novo Nordisk Business Overview
11.13.3 Novo Nordisk Binge Eating Disorder Treatment Introduction
11.13.4 Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.13.5 Novo Nordisk Recent Development
11.14 Omeros Corp
11.14.1 Omeros Corp Company Details
11.14.2 Omeros Corp Business Overview
11.14.3 Omeros Corp Binge Eating Disorder Treatment Introduction
11.14.4 Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.14.5 Omeros Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Binge Eating Disorder Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medication
1.2.3 Services
1.3 Market by Application
1.3.1 Global Binge Eating Disorder Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Binge Eating Disorder Treatment Market Perspective (2020-2031)
2.2 Global Binge Eating Disorder Treatment Growth Trends by Region
2.2.1 Global Binge Eating Disorder Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Binge Eating Disorder Treatment Historic Market Size by Region (2020-2025)
2.2.3 Binge Eating Disorder Treatment Forecasted Market Size by Region (2026-2031)
2.3 Binge Eating Disorder Treatment Market Dynamics
2.3.1 Binge Eating Disorder Treatment Industry Trends
2.3.2 Binge Eating Disorder Treatment Market Drivers
2.3.3 Binge Eating Disorder Treatment Market Challenges
2.3.4 Binge Eating Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Binge Eating Disorder Treatment Players by Revenue
3.1.1 Global Top Binge Eating Disorder Treatment Players by Revenue (2020-2025)
3.1.2 Global Binge Eating Disorder Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Binge Eating Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Binge Eating Disorder Treatment Revenue
3.4 Global Binge Eating Disorder Treatment Market Concentration Ratio
3.4.1 Global Binge Eating Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Binge Eating Disorder Treatment Revenue in 2024
3.5 Global Key Players of Binge Eating Disorder Treatment Head office and Area Served
3.6 Global Key Players of Binge Eating Disorder Treatment, Product and Application
3.7 Global Key Players of Binge Eating Disorder Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Binge Eating Disorder Treatment Breakdown Data by Type
4.1 Global Binge Eating Disorder Treatment Historic Market Size by Type (2020-2025)
4.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2026-2031)
5 Binge Eating Disorder Treatment Breakdown Data by Application
5.1 Global Binge Eating Disorder Treatment Historic Market Size by Application (2020-2025)
5.2 Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Binge Eating Disorder Treatment Market Size (2020-2031)
6.2 North America Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Binge Eating Disorder Treatment Market Size by Country (2020-2025)
6.4 North America Binge Eating Disorder Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Binge Eating Disorder Treatment Market Size (2020-2031)
7.2 Europe Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Binge Eating Disorder Treatment Market Size by Country (2020-2025)
7.4 Europe Binge Eating Disorder Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Binge Eating Disorder Treatment Market Size (2020-2031)
8.2 Asia-Pacific Binge Eating Disorder Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Binge Eating Disorder Treatment Market Size (2020-2031)
9.2 Latin America Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Binge Eating Disorder Treatment Market Size by Country (2020-2025)
9.4 Latin America Binge Eating Disorder Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Binge Eating Disorder Treatment Market Size (2020-2031)
10.2 Middle East & Africa Binge Eating Disorder Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Chronos Therapeutics
11.1.1 Chronos Therapeutics Company Details
11.1.2 Chronos Therapeutics Business Overview
11.1.3 Chronos Therapeutics Binge Eating Disorder Treatment Introduction
11.1.4 Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.1.5 Chronos Therapeutics Recent Development
11.2 Shire US Inc. (part of Takeda Pharmaceutical Company)
11.2.1 Shire US Inc. (part of Takeda Pharmaceutical Company) Company Details
11.2.2 Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
11.2.3 Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Introduction
11.2.4 Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.2.5 Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Company Details
11.3.2 Eli Lilly and Company Business Overview
11.3.3 Eli Lilly and Company Binge Eating Disorder Treatment Introduction
11.3.4 Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.3.5 Eli Lilly and Company Recent Development
11.4 Sunovion Pharmaceuticals Inc
11.4.1 Sunovion Pharmaceuticals Inc Company Details
11.4.2 Sunovion Pharmaceuticals Inc Business Overview
11.4.3 Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Introduction
11.4.4 Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.4.5 Sunovion Pharmaceuticals Inc Recent Development
11.5 Promises Behavioral Health
11.5.1 Promises Behavioral Health Company Details
11.5.2 Promises Behavioral Health Business Overview
11.5.3 Promises Behavioral Health Binge Eating Disorder Treatment Introduction
11.5.4 Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.5.5 Promises Behavioral Health Recent Development
11.6 Pyramid Healthcare (Tapestry Eating Disorder Services)
11.6.1 Pyramid Healthcare (Tapestry Eating Disorder Services) Company Details
11.6.2 Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
11.6.3 Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Introduction
11.6.4 Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.6.5 Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
11.7 Timberline Knolls
11.7.1 Timberline Knolls Company Details
11.7.2 Timberline Knolls Business Overview
11.7.3 Timberline Knolls Binge Eating Disorder Treatment Introduction
11.7.4 Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.7.5 Timberline Knolls Recent Development
11.8 Rosewood Centers for Eating Disorders
11.8.1 Rosewood Centers for Eating Disorders Company Details
11.8.2 Rosewood Centers for Eating Disorders Business Overview
11.8.3 Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Introduction
11.8.4 Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.8.5 Rosewood Centers for Eating Disorders Recent Development
11.9 Walden Behavioral Care
11.9.1 Walden Behavioral Care Company Details
11.9.2 Walden Behavioral Care Business Overview
11.9.3 Walden Behavioral Care Binge Eating Disorder Treatment Introduction
11.9.4 Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.9.5 Walden Behavioral Care Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Binge Eating Disorder Treatment Introduction
11.10.4 Roche Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Opiant Pharmaceuticals
11.11.1 Opiant Pharmaceuticals Company Details
11.11.2 Opiant Pharmaceuticals Business Overview
11.11.3 Opiant Pharmaceuticals Binge Eating Disorder Treatment Introduction
11.11.4 Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.11.5 Opiant Pharmaceuticals Recent Development
11.12 Heptares
11.12.1 Heptares Company Details
11.12.2 Heptares Business Overview
11.12.3 Heptares Binge Eating Disorder Treatment Introduction
11.12.4 Heptares Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.12.5 Heptares Recent Development
11.13 Novo Nordisk
11.13.1 Novo Nordisk Company Details
11.13.2 Novo Nordisk Business Overview
11.13.3 Novo Nordisk Binge Eating Disorder Treatment Introduction
11.13.4 Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.13.5 Novo Nordisk Recent Development
11.14 Omeros Corp
11.14.1 Omeros Corp Company Details
11.14.2 Omeros Corp Business Overview
11.14.3 Omeros Corp Binge Eating Disorder Treatment Introduction
11.14.4 Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2020-2025)
11.14.5 Omeros Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Binge Eating Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medication
Table 3. Key Players of Services
Table 4. Global Binge Eating Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Binge Eating Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Binge Eating Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Binge Eating Disorder Treatment Market Share by Region (2020-2025)
Table 8. Global Binge Eating Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Binge Eating Disorder Treatment Market Share by Region (2026-2031)
Table 10. Binge Eating Disorder Treatment Market Trends
Table 11. Binge Eating Disorder Treatment Market Drivers
Table 12. Binge Eating Disorder Treatment Market Challenges
Table 13. Binge Eating Disorder Treatment Market Restraints
Table 14. Global Binge Eating Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Binge Eating Disorder Treatment Market Share by Players (2020-2025)
Table 16. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2024)
Table 17. Ranking of Global Top Binge Eating Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Binge Eating Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Binge Eating Disorder Treatment, Headquarters and Area Served
Table 20. Global Key Players of Binge Eating Disorder Treatment, Product and Application
Table 21. Global Key Players of Binge Eating Disorder Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Binge Eating Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Binge Eating Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Binge Eating Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Chronos Therapeutics Company Details
Table 47. Chronos Therapeutics Business Overview
Table 48. Chronos Therapeutics Binge Eating Disorder Treatment Product
Table 49. Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 50. Chronos Therapeutics Recent Development
Table 51. Shire US Inc. (part of Takeda Pharmaceutical Company) Company Details
Table 52. Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
Table 53. Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Product
Table 54. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 55. Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
Table 56. Eli Lilly and Company Company Details
Table 57. Eli Lilly and Company Business Overview
Table 58. Eli Lilly and Company Binge Eating Disorder Treatment Product
Table 59. Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 60. Eli Lilly and Company Recent Development
Table 61. Sunovion Pharmaceuticals Inc Company Details
Table 62. Sunovion Pharmaceuticals Inc Business Overview
Table 63. Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Product
Table 64. Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 65. Sunovion Pharmaceuticals Inc Recent Development
Table 66. Promises Behavioral Health Company Details
Table 67. Promises Behavioral Health Business Overview
Table 68. Promises Behavioral Health Binge Eating Disorder Treatment Product
Table 69. Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 70. Promises Behavioral Health Recent Development
Table 71. Pyramid Healthcare (Tapestry Eating Disorder Services) Company Details
Table 72. Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
Table 73. Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Product
Table 74. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 75. Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
Table 76. Timberline Knolls Company Details
Table 77. Timberline Knolls Business Overview
Table 78. Timberline Knolls Binge Eating Disorder Treatment Product
Table 79. Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 80. Timberline Knolls Recent Development
Table 81. Rosewood Centers for Eating Disorders Company Details
Table 82. Rosewood Centers for Eating Disorders Business Overview
Table 83. Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Product
Table 84. Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 85. Rosewood Centers for Eating Disorders Recent Development
Table 86. Walden Behavioral Care Company Details
Table 87. Walden Behavioral Care Business Overview
Table 88. Walden Behavioral Care Binge Eating Disorder Treatment Product
Table 89. Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 90. Walden Behavioral Care Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Binge Eating Disorder Treatment Product
Table 94. Roche Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Opiant Pharmaceuticals Company Details
Table 97. Opiant Pharmaceuticals Business Overview
Table 98. Opiant Pharmaceuticals Binge Eating Disorder Treatment Product
Table 99. Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 100. Opiant Pharmaceuticals Recent Development
Table 101. Heptares Company Details
Table 102. Heptares Business Overview
Table 103. Heptares Binge Eating Disorder Treatment Product
Table 104. Heptares Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 105. Heptares Recent Development
Table 106. Novo Nordisk Company Details
Table 107. Novo Nordisk Business Overview
Table 108. Novo Nordisk Binge Eating Disorder Treatment Product
Table 109. Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 110. Novo Nordisk Recent Development
Table 111. Omeros Corp Company Details
Table 112. Omeros Corp Business Overview
Table 113. Omeros Corp Binge Eating Disorder Treatment Product
Table 114. Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 115. Omeros Corp Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Binge Eating Disorder Treatment Picture
Figure 2. Global Binge Eating Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Binge Eating Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medication Features
Figure 5. Services Features
Figure 6. Global Binge Eating Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Binge Eating Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Binge Eating Disorder Treatment Report Years Considered
Figure 11. Global Binge Eating Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Binge Eating Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Binge Eating Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 14. Global Binge Eating Disorder Treatment Market Share by Players in 2024
Figure 15. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Binge Eating Disorder Treatment Revenue in 2024
Figure 17. North America Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 19. United States Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 23. Germany Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Binge Eating Disorder Treatment Market Share by Region (2020-2031)
Figure 31. China Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 39. Mexico Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 43. Turkey Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Chronos Therapeutics Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 47. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 48. Eli Lilly and Company Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 49. Sunovion Pharmaceuticals Inc Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 50. Promises Behavioral Health Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 51. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 52. Timberline Knolls Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 53. Rosewood Centers for Eating Disorders Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 54. Walden Behavioral Care Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 55. Roche Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 56. Opiant Pharmaceuticals Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 57. Heptares Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 58. Novo Nordisk Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 59. Omeros Corp Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Binge Eating Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Medication
Table 3. Key Players of Services
Table 4. Global Binge Eating Disorder Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Binge Eating Disorder Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Binge Eating Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Binge Eating Disorder Treatment Market Share by Region (2020-2025)
Table 8. Global Binge Eating Disorder Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Binge Eating Disorder Treatment Market Share by Region (2026-2031)
Table 10. Binge Eating Disorder Treatment Market Trends
Table 11. Binge Eating Disorder Treatment Market Drivers
Table 12. Binge Eating Disorder Treatment Market Challenges
Table 13. Binge Eating Disorder Treatment Market Restraints
Table 14. Global Binge Eating Disorder Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Binge Eating Disorder Treatment Market Share by Players (2020-2025)
Table 16. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2024)
Table 17. Ranking of Global Top Binge Eating Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Binge Eating Disorder Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Binge Eating Disorder Treatment, Headquarters and Area Served
Table 20. Global Key Players of Binge Eating Disorder Treatment, Product and Application
Table 21. Global Key Players of Binge Eating Disorder Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Binge Eating Disorder Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Binge Eating Disorder Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Binge Eating Disorder Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Binge Eating Disorder Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Binge Eating Disorder Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Binge Eating Disorder Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Binge Eating Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Binge Eating Disorder Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Binge Eating Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Binge Eating Disorder Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Chronos Therapeutics Company Details
Table 47. Chronos Therapeutics Business Overview
Table 48. Chronos Therapeutics Binge Eating Disorder Treatment Product
Table 49. Chronos Therapeutics Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 50. Chronos Therapeutics Recent Development
Table 51. Shire US Inc. (part of Takeda Pharmaceutical Company) Company Details
Table 52. Shire US Inc. (part of Takeda Pharmaceutical Company) Business Overview
Table 53. Shire US Inc. (part of Takeda Pharmaceutical Company) Binge Eating Disorder Treatment Product
Table 54. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 55. Shire US Inc. (part of Takeda Pharmaceutical Company) Recent Development
Table 56. Eli Lilly and Company Company Details
Table 57. Eli Lilly and Company Business Overview
Table 58. Eli Lilly and Company Binge Eating Disorder Treatment Product
Table 59. Eli Lilly and Company Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 60. Eli Lilly and Company Recent Development
Table 61. Sunovion Pharmaceuticals Inc Company Details
Table 62. Sunovion Pharmaceuticals Inc Business Overview
Table 63. Sunovion Pharmaceuticals Inc Binge Eating Disorder Treatment Product
Table 64. Sunovion Pharmaceuticals Inc Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 65. Sunovion Pharmaceuticals Inc Recent Development
Table 66. Promises Behavioral Health Company Details
Table 67. Promises Behavioral Health Business Overview
Table 68. Promises Behavioral Health Binge Eating Disorder Treatment Product
Table 69. Promises Behavioral Health Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 70. Promises Behavioral Health Recent Development
Table 71. Pyramid Healthcare (Tapestry Eating Disorder Services) Company Details
Table 72. Pyramid Healthcare (Tapestry Eating Disorder Services) Business Overview
Table 73. Pyramid Healthcare (Tapestry Eating Disorder Services) Binge Eating Disorder Treatment Product
Table 74. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 75. Pyramid Healthcare (Tapestry Eating Disorder Services) Recent Development
Table 76. Timberline Knolls Company Details
Table 77. Timberline Knolls Business Overview
Table 78. Timberline Knolls Binge Eating Disorder Treatment Product
Table 79. Timberline Knolls Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 80. Timberline Knolls Recent Development
Table 81. Rosewood Centers for Eating Disorders Company Details
Table 82. Rosewood Centers for Eating Disorders Business Overview
Table 83. Rosewood Centers for Eating Disorders Binge Eating Disorder Treatment Product
Table 84. Rosewood Centers for Eating Disorders Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 85. Rosewood Centers for Eating Disorders Recent Development
Table 86. Walden Behavioral Care Company Details
Table 87. Walden Behavioral Care Business Overview
Table 88. Walden Behavioral Care Binge Eating Disorder Treatment Product
Table 89. Walden Behavioral Care Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 90. Walden Behavioral Care Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Binge Eating Disorder Treatment Product
Table 94. Roche Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Opiant Pharmaceuticals Company Details
Table 97. Opiant Pharmaceuticals Business Overview
Table 98. Opiant Pharmaceuticals Binge Eating Disorder Treatment Product
Table 99. Opiant Pharmaceuticals Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 100. Opiant Pharmaceuticals Recent Development
Table 101. Heptares Company Details
Table 102. Heptares Business Overview
Table 103. Heptares Binge Eating Disorder Treatment Product
Table 104. Heptares Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 105. Heptares Recent Development
Table 106. Novo Nordisk Company Details
Table 107. Novo Nordisk Business Overview
Table 108. Novo Nordisk Binge Eating Disorder Treatment Product
Table 109. Novo Nordisk Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 110. Novo Nordisk Recent Development
Table 111. Omeros Corp Company Details
Table 112. Omeros Corp Business Overview
Table 113. Omeros Corp Binge Eating Disorder Treatment Product
Table 114. Omeros Corp Revenue in Binge Eating Disorder Treatment Business (2020-2025) & (US$ Million)
Table 115. Omeros Corp Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Binge Eating Disorder Treatment Picture
Figure 2. Global Binge Eating Disorder Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Binge Eating Disorder Treatment Market Share by Type: 2024 VS 2031
Figure 4. Medication Features
Figure 5. Services Features
Figure 6. Global Binge Eating Disorder Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Binge Eating Disorder Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Binge Eating Disorder Treatment Report Years Considered
Figure 11. Global Binge Eating Disorder Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Binge Eating Disorder Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Binge Eating Disorder Treatment Market Share by Region: 2024 VS 2031
Figure 14. Global Binge Eating Disorder Treatment Market Share by Players in 2024
Figure 15. Global Top Binge Eating Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Binge Eating Disorder Treatment Revenue in 2024
Figure 17. North America Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 19. United States Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 23. Germany Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Binge Eating Disorder Treatment Market Share by Region (2020-2031)
Figure 31. China Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 39. Mexico Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Binge Eating Disorder Treatment Market Share by Country (2020-2031)
Figure 43. Turkey Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Binge Eating Disorder Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Chronos Therapeutics Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 47. Shire US Inc. (part of Takeda Pharmaceutical Company) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 48. Eli Lilly and Company Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 49. Sunovion Pharmaceuticals Inc Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 50. Promises Behavioral Health Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 51. Pyramid Healthcare (Tapestry Eating Disorder Services) Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 52. Timberline Knolls Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 53. Rosewood Centers for Eating Disorders Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 54. Walden Behavioral Care Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 55. Roche Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 56. Opiant Pharmaceuticals Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 57. Heptares Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 58. Novo Nordisk Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 59. Omeros Corp Revenue Growth Rate in Binge Eating Disorder Treatment Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232